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ABSTRACT

This invention provides materials and methods to manipulate
the plant genome at the level of single plant cells in culture
resulting in the ability to assign metabolic functionality to
plant genes involved in the production of biologically active
molecules and to create a means of product discovery based

on the biosynthetic capacity of plants. The materials to create
an activation mutagenesis include incorporation of enhancer
sequences from a plant viral promoter at random places in the
plant genome via Agrobacterium mediated DNA transfer
(T-DNA). The usefulness is that genes in the immediate vicin
ity of the incorporation were activated which allows for

immediate screening of the mutageniZed plant cells. Addi
tionally, the usefulness includes relevant areas of the genome
were ?anked by the inserted T-DNA which allows recovery of

this area by standard molecular biology techniques. The
method includes a procedure for screening large numbers of
mutageniZed plant cell cultures for activation of a relevant
gene on the basis of the desired protein product on the basis of

radioligand binding displacement assay.
12 Claims, 11 Drawing Sheets
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METHODS TO IDENTIFY PLANT
METABOLITES

information available to the applicant and does not constitute
any admission as to the accuracy of the dates or contents of

these documents.
CROSS REFERENCE TO RELATED
APPLICATION

SUMMARY OF THE INVENTION

This application is a divisional ofU.S. application Ser. No.
10/045,677, ?led Jan. 15, 2002 now US. Pat. No. 6,989,236,

The present invention provides a method for identifying
plant genetic material Whose actions cause increased produc

Which claims bene?t of priority from US. Provisional Appli
cation Ser. No. 60,267,438, ?led Feb. 9, 2001.

tion of a metabolite or metabolites of interest in plant cells,

said method comprising causing random integration into the
plant genome in plant protoplasts of at least one enhancer

containing T-DNA genetic element harboring sequences to
enable bacterial replication and selection; groWing said pro
toplasts to the stage of callus cultures; sampling said callus

BACKGROUND OF THE INVENTION
Plants are sources of drugs and other useful materials.

These materials are the products of plant metabolism, Which
is the total collection of biochemical pathWays Within a plant.
Genes encode the enzymes that function in plant metabolic
pathWays and regulatory genes, in turn, control the activity of

metabolic pathWays by directing the expression of entire sets
of enzyme-encoding genes speci?c to a given pathWay. It

cultures in such a manner as to retain viability of said clonal

20

folloWs that methods to identify any genes that govern the
production of such plant metabolites are critical to enable the

cultures; analyzing said samples to identify the callus cultures
producing metabolite or metabolites of interest; and isolating
and identifying the plant genetic material, the action of Which
has been stimulated by the enhancer-containing T-DNA
genetic element in the sampled, identi?ed callus cultures.
Preferred is a method Wherein the plant genetic material,
Which is identi?ed, is a plant gene Whose action causes a plant

manipulation of pathWays for elevating product yield and for

cell to produce an increased amount of a metabolite or

increasing the diversity of these substances. The present
invention provides methods to identify, in a relatively e?i
cient and reliable manner, plant-genetic material required for
production of metabolites Which Would ordinarily be dif?cult

metabolites of interest. More preferred is a method Wherein
25

the plant genetic material, Which is identi?ed, is a regulatory
gene. Also preferred is a method Wherein the analysis of
callus cultures detects the production of metabolites of inter

to identify. The invention is the realization of the successful

est having pharmacological properties. Most preferred is a

merging of tWo distinct methodologies: activation-tagging
mutagenesis and high-throughput screening. The present
unique combination of these methodologies results in the
ability to assign metabolic functionality to plant genes
involved in the production of biologically active molecules

method Wherein said metabolites are detected via at least one
30

Methods of the present invention, Which comprises the
further step of propagating at least one callus, culture produc

and to create a means of compound discovery based on the

genetic capabilities of a plant or group of plants.

35

This invention is therefore based on the folloWing technical

developments: 1) methodology Which enables propagation
and maintenance of mutagenized “microcallus” material in a
“library” format in such a Way as to permit large scale screen

ing; 2) procedures to nondestructively sample the microcal

radioligand displacement assay.

40

ing said metabolite or metabolites. Most preferred are meth
ods, Which involve a tobacco plant.
Most preferred are methods Wherein said enhancer
sequence is a plant viral enhancer sequence.
Most preferred are methods Wherein said enhancer
sequence is delivered to the plant via A grobaclerium Zumefa
ciens.
Preferred are methods Wherein said radioligand is a nico

lus; 3) methodology to screen the microcallus sample in a

tinic acetylcholine agonist or a nicotinic acetylcholine

miniaturized high throughput pharmacological screen.

antagonist. Mo st preferred is the radioligand [3 H] -epibatidine
or [3 H] -methyllycaconitine.

Therefore, the invention is in the ?eld of plant molecular

biology, in particular, genetic methods for production and
identi?cation of useful compounds.
Identi?cation of plant genes via activation mutagenesis has

45

The present invention provides a method for identifying
plant genetic material Whose actions cause increased produc
tion of a metabolite or metabolites of interest in plant cells,

been used With success previous to the present invention. This

said method comprising co-cultivating plant protoplasts With

technique involves incorporation of enhancer sequences from
a plant viral promoter at random places into the plant genome
via A grobaclerium mediated T-DNA transfer. When applied
to single plant cells in culture, the resulting mutants are iden
ti?ed by positive selection, and the gene(s) in the vicinity of

Agrobaclerium cells harboring an activation-tagging vector;
embedding the plant protoplasts in agarose; transferring the
50

the T-DNA insert is cloned. HoWever, elucidation of the
effects of mutations in regulatory regions, or doWnstream
effects from a mutagenized gene, are very dif?cult in cases

embedded protoplasts to a larger surface area to alloW further

groWth; excising individual, clonal calli resulting from said
groWth; partially macerating individual samples of tissue
from said calli in multi-Welled microtiter plates to establish a

sample clonal library; removing supernatant liquid fractions
55

from said macerated samples; subjecting said supernatant

Where no positive selection schemes can be employed. Even

fractions to radioligand displacement assays to determine if

With classical activation mutagenesis methods, Walden et al.

metabolites in the liquid supernatant displace the radioligand;
adding groWth medium to remaining tissues in the microtiter

conclude “this process is involved, labor-intensive and can

only be effectively carried out With relatively limited numbers
of segregating individuals.” Walden et al., Methods in Cell

plate; and isolating and identifying the plant genetic material,
60

Biology, 49:455-469 (1995).

erated ligand displacement in the radioligand displacement

High-throughput screening has also been utilized in the

pharmaceutical ?eld.

assay.

Citation of the above document is not intended as an admis

sion that any of the foregoing is pertinent prior art. All state
ments as to the date or representation as to the contents of

these documents is based on subjective characterization of

the action of Which has been stimulated by the action of the
activation-tagging vector, from the callus cultures Which gen

65

The present invention provides methods for detecting a
metabolite in a plant comprising: causing integration of at
least one enhancer-containing T-DNA in a plant protoplast;
groWing said protoplast to the stage of callus culture; sam

US 7,547,520 B2
3

4

pling said callus in such a manner so as to retain viability of

FIG. 2B shoWs a photograph of a cluster of clonal cells after

said callus culture; and detecting a metabolite of interest.
Those methods Wherein said metabolite is detected via at
least one radioligand displacement assay are preferred. More
preferred are methods as described Which further comprise
the step of continuous propagation of at least one stably
transformed culture.
In the present invention, methods Wherein the plant is a

several steps of incubation, Washing, antibiotic selection and
embedding of the multiplied protoplasts. The clusters of
clonal cells become macroscopic (referred to as “microcalli”)
as shoWn in the dish in the right of the ?gure. Diameter of the
petri dish shoWn is 150 mm.
FIGS. 3A-B. FIG. 3A shoWs a photograph of a plate of

surface-embedded calli after propagation for approximately

tobacco plant are preferred. Those methods Wherein said

?ve Weeks (compare to microcalli in FIG. 2). This is an

enhancer sequence is a plant viral enhancer sequence are also

example of the type of density used of mutageniZed material

preferred. Most preferred are those methods, Which utiliZe a
viral enchancer sequence, delivered via A grobaclerium lume

used for sampling to conduct the pharmacological assay. FIG.
3B shoWs a photograph of a standard 48-well plate shoWing

faciens.

regroWth of the mutageniZed callus tissue after sampling and

When the detection means is a radioligand displacement
assay, methods Wherein said radioligand is a nicotinic acetyl
choline agonist or a nicotinic acetylcholine antagonist are

approximately three Weeks previously.

extract preparation Which took place in the same Wells
FIG. 4 shoWs a photograph of an “activation-tagging

preferred. In particular, those methods Wherein said radioli
gand is [3 H] -epibatidine are more preferred.

mutagenesis” (ATM) library that harbors over 1300 indi
vidual mutant clones. This illustrates the Workability of estab
lishing a viable “master” library developed using the methods

Also provided are methods for detecting a metabolite in a

plant comprising: co-cultivating protoplasts With Agrobacte

20

described herein.

25

screen-positive callus clone that had been physically divided
and propagated as approximately 20 clonal pieces of separate
callus tissue. This is used for veri?cation of the pharmaco
logical phenotype, as each “daughter” individual is expected

rial cells harboring an activation tagging vector; embedding
the protoplasts in agarose; transferring protoplasts to a larger
surface area to alloW further groWth; excising individual calli
tissue; partially macerating individual calli tissue in a multi
Welled microtitre plate; establishing a viable callus library;

FIGS. 5A-B. FIG. 5A shoWs a photograph of an individual

removing liquid supernatant; adding groWth medium to tis
sues remaining in the microtitre plate; and conducting radio

to have the same displacement activity as the “parental” tis
sue. FIG. 5B shoWs that such pieces are also used for plant

ligand displacement assay to determine if a metabolite dis

regeneration from the calli (right half).

places the radioligand.
For the purposes of the present invention, the term “a” or
“an” entity refers to one or more of that entity; for example, “a

30

scored as positive in the screen.

FIG. 7 shoWs a graph of displacement data of a population

metabolite” or “a radioligan ” or “an assay” refers to one or

more of those compounds or at least one compound. As such,
the terms “a” (or “an”), “one or more” and “at least one” can
be used interchangeably herein. It is also to be noted that the

of mutant (“ATM”) and Wild type (“no ATM”) using 3H-epi
batidine as the ligand in the pharmacological screen. Non
35

the group consisting of’ refers to one or more of the com

pounds in the list that folloWs, including mixtures (i.e. com
40

from its natural milieu. As such, “isolated” and “biologically
pure” do not necessarily re?ect the extent to Which the com

pound has been puri?ed. An isolated compound of the present

45

invention can be obtained from its natural source, can be

produced using molecular biology techniques or can be pro

duced by chemical synthesis.
These and other objects of the invention Will be more fully

understood from the folloWing description of the invention,

50

the referenced draWings attached hereto and the claims
BRIEF DESCRIPTION OF THE DRAWINGS

The present invention Will become more fully understood

the 1402 extract is distinct from Wildtype and is most likely a

compound other than nicotine.

from the detailed description given herein beloW, and the
accompanying draWing, Which is given by Way of illustration

FIG. 10 shoWs a summary of the molecular characteriza
tion of cell line 1402.
60

DETAILED DESCRIPTION OF THE INVENTION

The present invention provides a method for identifying
plant genetic material Whose actions cause increased produc

FIGS. 2A-B. FIG. 2A shoWs a photograph taken through a

bright ?eld microscope (40>< magni?cation) of freshly iso

resulting in the insertion of the activation-tagging T-DNA.

lines and Wild-type controls expressed in terms of “nicotine
displacement activity” or approximately equivalent to a given
concentration of nicotine in the displacement assay. Note log
scale on the Y-axis. The upper clone represents activity
10,000 times higher than that found in Wild-type calli. This
line is no. 7309. The line With the loWest activity (and regen
erated and analyZed at the Whole plant level) is no. 1402.
FIGS. 9A-D. FIGS. 9A and 9B shoW initial activity char
acteriZation by displacement activity of line no. 1402 callus
(See discussion text). The pure anabasine alkaoid and pure

ence in the shape of the pro?les indicates that the activity in
55

lated protoplasts from tobacco leaves tWo days after isolation.
At seven days the protoplasts are co-cultivated With A grobac
Zerium Zumefacians (GV3l0l) to conduct transformation

are typical for many thousands of assays run to date.
FIG. 8 shoWs a summary of activities of positive mutant

nicotine alkaloid are used here to standardiZe the system.
FIGS. 9C and 9D shoW characterization of crude callus
extracts performed in the same Way as that in A. This differ

appended hereto.

only, and thus is not limitative of the present invention.
FIG. 1 shoWs a protoplast isolation and transformation
?owchart.

mutated samples shoW average displacement of approxi
mately 3% Whereas the ATM population indicates tWo
individuals With greater than 30 and 70% displacement activ
ity, respectively. Note the log scale on the X-axis. These data

terms “comprising”, “including”, and “having” can be used
interchangeably. Furthermore, a compound “selected from
binations) of tWo or more of the compounds. According to the
present invention, an isolated or biologically pure, protein or
nucleic acid molecule is a compound that has been removed

FIG. 6 shoWs a photograph of plants groWing on synthetic
media in Magenta boxes that had been regenerated from calli

tion of a metabolite or metabolites of interest in plant cells,
65

said method comprising causing random or directed integra
tion into the plant genome in plant protoplasts of at least one

enhancer-containing T-DNA genetic element harboring

US 7,547,520 B2
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sequences to enable bacterial replication and selection; groW

ing said protoplasts to the stage of callus cultures; sampling

preferred. Most preferred are those methods, Which utiliZe a
viral enhancer sequence, delivered via A grobaclerium lume

said callus cultures in such a manner as to retain viability of

faciens.

said clonal cultures; analyzing said samples to identify the
the action of Which has been stimulated by the enhancer

When the detection means is a radioligand displacement
assay, methods Wherein said radioligand is a nicotinic acetyl
choline agonist or a nicotinic acetylcholine antagonist are
preferred. In particular, those methods Wherein said radioli

containing T-DNA genetic element in the sampled, identi?ed

gand is [3 H] -epibatidine are more preferred.

callus cultures producing metabolite or metabolites of inter

est; and isolating and identifying the plant genetic material,

Also provided are methods for detecting a metabolite in a

callus cultures.

plant comprising: co-cultivation of protoplasts WithAgrobac

Preferred is a method Wherein the plant genetic material,

terial cells harboring an activation-tagging vector; embed
ding the protoplasts in agarose; transferring protoplasts to a
larger surface area to alloW further groWth; excising indi

Which is identi?ed, is a plant gene Whose action causes a plant
cell to produce an increased amount of a metabolite or

metabolites of interest. More preferred is a method Wherein

vidual calli tissue; partially macerating individual calli tissue
in multi-Welled microtitre plate; removing liquid supernatant;

the plant genetic material, Which is identi?ed, is a regulatory
gene. Also preferred is a method Wherein the analysis of
callus cultures detects the production of metabolites of inter

conducting radioligand displacement assay to determine if a

metabolite displaces the radioligand; and adding groWth

est having pharmacological properties. Most preferred is a

medium to tissues remaining in the microtitre plate.

method Wherein said metabolites are detected via at least one

radioligand displacement assay.
Methods of the present invention may also comprise the
further step of propagating at least one callus culture produc
ing said metabolite or metabolites. Most preferred are meth
ods, Which involve a tobacco plant and Wherein said enhancer
sequence is a plant viral enhancer sequence.
Most preferred are methods Wherein said enhancer
sequence is delivered to the plant via A grobaclerium Zumefa

Other methods of transformation include: biolistic bom
20

Plant cells may also be transformed With other sequences
With the ability to cause the activation of genes such as
25

ciens.
Preferred are methods Wherein said radioligand is a nico

tinic acetylcholine agonist or a nicotinic acetylcholine

30

enhancer sequences from different promoters and sequences
encoding transcription factors that can function to activate
gene expression or from the introduction of populations of
genes in order to determine their impact on metabolite pro
duction.

The supernatant may be assayed for products of secondary
metabolism With radiolabelled ligand binding assays. Pre
ferred ligands are acetylcholine agonists and antagonists.

More preferred are 3H-methyllycaconitine, 3H-spermidine.
Most preferred is 3H-epibatidine.

antagonist. Mo st preferred is the radioligand [3 H] -epibatidine
or [3H]-methyllycaconitine.
In a preferred embodiment, the present invention provides
a method for identifying plant genetic material Whose actions

Preferred enhancer sequences include tissue-speci?c pro
moter enhancers and temporal-speci?c promoter enhancers.
Most preferred is a constitutive plant viral promoter active in
plant cells and undifferentiated callus tissue.

cause increased production of a metabolite or metabolites of

interest in plant cells, said method comprising co-cultivating
plant protoplasts With A grobaclerium cells harboring an acti
vation-tagging vector; embedding the plant protoplasts in
agarose; transferring the embedded protoplasts to a larger
surface area to alloW further groWth; excising individual,

bardment and polyethylene glycol-mediated DNA uptake.

Enhancer sequences may be contained Within vectors

enabling the transfer of said sequences into the plant genome.
40

The term “antagonist” is intended to refer to that Which is
understood in the art. In general, the term refers to a sub stance

clonal calli resulting from said groWth; partially macerating

that interferes With receptor function. Antagonists are of tWo

individual samples of tissue from said calli in multi-Welled
microtiter plates to establish a sample clonal library; remov

types: competitive and non-competitive. A competitive
antagonist (or competitive blocker) competes With the natu

ing supernatant liquid fractions from said macerated samples;
subjecting said supernatant fractions to radioligand displace

45

ment assays to determine if metabolites in the liquid super

rally occurring ligand for the same binding site. In the case of
acetylcholine, an example of such an antagonist is bungaro
toxin. A non-competitive antagonist or blocker inactivates the
functioning of the receptor by binding to a site other than the

natant displace the radioligand; adding groWth medium to
remaining tissues in the microtiter plate; and isolating and
identifying the plant genetic material, the action of Which has
been stimulated by the action of the activation-tagging vector,
from the callus cultures Which generated ligand displacement
in the radioligand displacement assay.

50

The present invention provides methods for detecting a
metabolite in a plant comprising: causing integration of at
least one enhancer-containing T-DNA in a plant protoplast;
groWing said protoplast to the stage of callus culture; sam

55

system. There are also complex interactions betWeen cholin
ergic receptors and the function of receptors of other neu
rotransmitters such as dopamine, serotonin and catechola
mines.

60

autonomic ganglia, at the postganglionic parasympathetic

acetylcholine-binding site.

Cholinergic receptors play an important role in the function
ing of muscles, organs and generally in the central nervous

pling said callus in such a manner so as to retain viability of

said callus culture; and detecting a metabolite of interest in
the event that the metabolite of interest is present. Those

Speci?cally, the radiolabeled ligand may bind nicotinic

acetylcholine receptors. The preferred radiolabeled ligand is
[3H]-epibatidine, a nicotinic cholinergic receptor agonist.

Acetylcholine (ACh) serves as the neurotransmitter at all

methods Wherein said metabolite is detected via at least one

nerve endings, and at the postganglionic sympathetic nerve

radioligand displacement assay are preferred. More preferred

endings innervating the eccrine sWeat glands. Different

are methods as described Which further comprise the step of
propagating at least one daughter culture.

receptors for ACh exist on the postganglionic neurons Within

In the present invention, methods Wherein the plant is a
tobacco plant are preferred. Those methods Wherein said
enhancer sequence is a plant viral enhancer sequence are also

65

the autonomic ganglia and at the postjunctional autonomic
effector sites. Those Within the autonomic ganglia and adre
nal medulla are stimulated predominantly by nicotine and are
knoWn as nicotinic receptors. Those on autonomic effector
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cells are stimulated primarily by the alkaloid muscarine and

folloWing day, 250 ml beakers Were mixed for 10 min on an

are known as muscarinic receptors.

orbital shaker (approximately 40 rpm), and the solution Was
passed through a 105 um mesh sieve by pouring through a

The nicotinic receptors of autonomic ganglia and skeletal
muscle are not homogenous because they can be blocked by
different antagonists. For example, d-tubocurarine effec
tively blocks nicotinic response in skeletal muscle, Whereas

?ltration apparatus. This Was divided into 17><100 mm sterile

plastic centrifuge tubes, Which Were then centrifuged at 2000
rpm in a sWinging bucket rotor for 6 minutes at room tem

hexamethonium and mecamylamine are more effective in

perature. Following the centrifugation, protoplasts, Which

blocking nicotinic responses in autonomic ganglia. The nico
tinic cholinergic receptors are named the NM and NN recep

?oat at the top of the media in the centrifuge tube, Were

tors, respectively.

removed from the pelleted debris by aspirating the loWer
contents of the tube. Protoplasts Were Washed by addition of
0.4M K3 media and recentrifuged. The protoplasts from these

Acetylcholine receptors at any or all of the above men

tioned locations may be assayed by radiolabeled ligand bind
ing assays in the present invention.

Were pooled into one or tWo single screW cap sterile tubes.

After adjusting protoplast cell density, cells Were further
incubated as 10 ml cultures in standard (60 mm) petri dishes.

EXAMPLES

Dishes Were Wrapped With para?lm for incubation at 260 C. in
the dark for tWo days.

The folloWing examples illustrate the present invention
Without, hoWever, limiting it. It is to be noted that the
Examples include a number of molecular biology, microbi
ology and biochemistry techniques considered to be knoWn to

Example 2

20

those skilled in the art. Disclosure of such techniques can be

Activation-Tagging Mutagenesis: Protoplast

found, for example, in Sambrook et al., ibid., and related
references.

Transformation

Example 1

25

Leaf Protoplast Preparation

1 986, Which is incorporated herein by reference in its entirety.
The plasmid pPCVlCEn4HPT containing the T-DNA tag Was

GroWing Conditions: Tobacco plants (Nicoliana Zabacum
SR1) Were groWn in sterile culture on MS media (One liter
contains: 4.3 g MS basal salt mixture (Sigma), 0.5 g MES

Materials: Agrobaclerium Zumefaciens strain GV3101, is
described in KoncZ and Schell, Mol Gen Genet 204:383-396.

30

used. It Was made as described in FritZe and Walden, Methods

in Molecular Biology 44:281-294. 1995 and in Walden, FritZe

(2-[N-Morpholino]ethanesulfonic acid) (Sigma) for buffer

and Harling, Methods in Cell Biology 49:455-469. 1995,

ing, 10 g sucrose. The pH Was adjusted to 5.8 With KOH.

Which references are incorporated by reference herein in their

Media Was solidi?ed by adding Phytagel (Sigma) to 0.2%.
Sterilization Was by autoclaving in Magenta boxes. Magenta

35

boxes contained lids With a vent provided by a 2 cm diameter

hole covered With a single 0.45 pm pore siZe ?lter disc (Type

HA, Millipore) and tWo pieces of “Micropore” surgical tape
(3M). Plants groWn for four to ?ve Weeks at 240 C. under
approximately 1 10 umol m_2s_l light intensity Were used as a

40

source of leaf material.

Leaf Preparation Procedure: Under sterile conditions, leaf
tissue Was removed from the plants and cut into approxi
mately 1 cm2 pieces using a sharp scalpel or raZor blade.
Approximately 5 g of leaf material Was added to 20 ml ?lter

entirety. pPCVlCEn4HPT is derived from the pPCV vector
(KoncZ and Schell, Mol Gen. Genet 213:285-290, 1986) in
Which the T-DNA contains four tandemly repeated enhancer
elements derived from the 35S RNA promoter of the Cauli
?oWer mosaic virus, a hygromycin resistance marker for pro
toplast and plant selection and an E. coli plasmid sequence
that contains an E. coli origin of replication and an ampicillin
resistance gene.
Procedure: Transformation With the activator T-DNA tag
Was performed by co-cultivation With A grobaclerium lume

steriliZed enZyme solution (1.5% cellulase, 0.5% pectinase,

faciens harboring the T-DNA tagging element (strain
GV3101, plasmid pPCVlCEn4HPT). Freshly groWn bacte

(Sigma)) in K3 plant culture media. K3 media contains 10 ml

rial cells Were added directly to six to eight day-old protoplast

per liter of the folloWing stock solutions: NaH2PO4 (3 g/200

cultures in a ratio of 100:1 bacteria to protoplast cells. Co
cultivation Was conducted at 260 C. in the dark for 48 hr. At

ml); CaCl2 (18 g/200 ml); (NH4)2SO4 (2.7 g/200 ml); MgSO4
(5 g/200 ml); KNO3, (5 g/200 ml); NH4NO3 (2.7 g/200 ml).

45
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Added directly to one liter of K3 media Was inositol, 100 mg;

the end of the incubation period, protoplasts Were Washed
three times in W5 media by centrifugation in a sWing-out

xylose, 250 mg; and MES buffer, 2.0 g. In addition, K3 media

rotor at room temperature. W5 media contained NaCl, 9.0

also contained 10 ml per liter of a micronutrients solution and
1.0 ml per liter of a vitamin solution. The micronutrient

solution Was prepared by dissolving the folloWing into one
liter H2O: H3BO3, 6.2 g; MnSO4'4H2O, 22.3 g;
ZnSO4.7H2O, 10.6 g; Kl, 0.88 g; NaMoO4'2H2O, 0.25 g;
CuSO4'5H2O, 0.025 g; and CoCl2'6H2O, 0.025 g. The vita
min stock solution Was made by dissolving the folloWing in
200 ml H2O: glycine, 400 mg; nicotinic acid, 400 mg; pyri

g/liter; CaCl2'2H2O, 18.38 g/liter; KCl, 0.373 g/liter; and
glucose, 0.90 g/liter. The pH Was adjusted to 5.6-6.0, With
55

60

HCl. The medium Was steriliZed by autoclavation. Proto
plasts Were then resuspended in 0.4M K3 media to produce a
?nal concentration of 106 protoplasts per ml. One ml of
protoplast suspension Was transferred to a standard (100 mm)
petri dish and cultured in a ?nal volume of 10 ml of 0.4 M K3

doxin-HCl, 400 mg; thiamin-HCl, 20 mg. 5.0 ml of an Fe
EDTA solution Was added from a stock, prepared by dissolv

media containing antibiotic selection against A grobaclerium

ing 5.57 g FeSO4'7H2O and 7.45 g NaZEDTA. To prepare K3

mones to maintain cells in a dedifferentiated state (auxin

containing 0.4M sucrose, 136.92 g sucrose Was added. 0.1M
sucrose K3 media contains 34.23 g sucrose.

Protoplast Isolation: Leaves Were digested overnight (no
more than 19 h) by incubation at 260 C. in the dark. The

cells (cefotaxime 500 ug/ml) as Well as the presence of hor

(NAA) 1.0 ug/ml and cytokinin (kinetin 0.2 ug/ml). Hygro
65

mycin (15 ug/ml) Was also added to the incubation media to
select for the protoplasts transformed With the activation

tagging vector.
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Example 3

virtually 100%. Additional media is added to each Well to
increase the volume to 1.0 ml. 0.65 ml of the 1.0 ml volume of

Propagation of Protoplasts and Calli

cellular ?uid resulting from the partial callus maceration in
each Well is removed and transferred to standard 1.5 ml

micro-centrifuge tubes. After sealing the lids of the 48-Well
dishes With surgical tape (3M), they are placed in a lighted 26°
C. incubator for recovery and groWth. The groWing calli
Within the 48-Well dishes establishes the Working library.

Culturing of Protoplasts: Transformed cells Were embed
ded in 0.3% loW gelling temperature agarose in 100 mm petri
dishes. K4 media Was then added to the petri dishes contain

ing the soft agarose embedded microcalli. Following proto
plast embedding, the K4 media Was reduced in osmolarity in
0.1M increments, (starting at 0.4M sucrose, ~580 mOsm) on
a Weekly basis by changing the liquid phase media over the

Example 5
Extract Preparation

soft agarose embedded cells. “K4” media contains 10 ml per

liter of the folloWing stock solutions: NaHZPO4 (3 g/ 200 ml);
Micro-centrifuge tubes containing 0.65 ml of cell tissue

CaCl2 (18 g/200 ml); KCl (58.8 g/200 ml); glutamine (17.54
g/200 ml); asparagine (5.32 g/200 ml); arginine (3.52 g/200
ml); (NH4)2SO4 (2.7 g/200 ml); MgSO4 (5 g/200 ml). Added

ten minutes at room temperature. The supernatant is removed

directly to one liter of K4 media is inositol, 100 mg; xylose,
250 mg, and MES buffer, 2.0 g. In addition, K4 media also

and placed into clean micro-centrifuge tubes and stored at
—80° C. until used for displacement assays.

contains 10 ml per liter of a micronutrients solution and 1.0
ml per liter of a vitamin solution With the same composition as
that used for the K3 media as Well as 5.0 ml per liter of a

?uid and K4 groWth media are centrifuged at 13,000 rpm for

Example 6

20

[3H]-epibatidine Screening

Fe-EDTA solution and sucrose to 0.4 or 0.1M.

Transfer to Larger Areas for Additional GroWth: Once
microcalli Were established (usually four to ?ve Weeks), they
Were released from the agarose by gentle maceration and
dilution. Microcalli Were further cultured by “surface plat
ing” the transformed tissue onto 0.1M K4 media solidi?ed

Tissue Preparation: Crude membrane preparations from
25

brains of male adult Sprague-DaWley rats Were prepared from

30

methods modi?ed after Houghtling R A, Davila-Garcia M l,
Kellar K J, Mol Pharmacol 48(2):280-7, 1995, Which refer
ence is incorporated by reference herein in its entirety. Fol
loWing sacri?ce by rapid decapitation, the frontal cortex and
hippocampus Were rapidly dissected and homogeniZed in

With 0.8% agar in 150 mm dishes. The released microcalli
Were “re-embedded” in loW gelling-temperature agarose and

plated to the surface of solidi?ed K4 media agar plates. This
results in a 2 mm thick monolayer of embedded microcalli on

ice-cold sucrose buffer (0.32 M sucrose, 1 mM EDTA, 0.1

the plate such that further groWth forms an upWard protrusion
of the calli large enough for physical sampling. Dilutions

mM phenylmethylsulfonyl ?uoride, 0.01% Wt/vol sodium
aZide; pH adjusted to 7.4) using a polytron tissue homog

tinued groWth of the microcalli up to the stage of sampling.

eniZer. The homogenate Was centrifuged at 1000><g at 4° C.
for 10 min. The pellet Was resuspended in sucrose buffer and
the centrifugation repeated. The supernatant fractions Were

Example 4

centrifugation 15000><g at 4° C. for 20 min. The pellet Was

Were empirically made to adjust the number of individual
microcalli on each dish to densities suf?cient to enable con

35

combined and the P2 membranes recovered as a pellet after

Nondestructive Sampling and Library Establishment

40

Washed tWice by resuspension in phosphate buffer (same as
above, except 50 mM phosphate substituted for sucrose) and
centrifuged at 15000><g at 4° C. for 20 min. The ?nal pellet
Was resuspended in phosphate buffer. Protein Was determined

The three steps of sampling, establishment of a viable

Working library and extract preparation of surface-groWn

by the BCA Protein Assay kit from Pierce, Rockford Ill.

macrocalli are combined into a single process to maximiZe

Aliquots Were stored at —80° C. until use.

throughput. Surface-embedded microcalli groWn to siZes
ranging from approximately 0.5 cm to 1.5 cm (“macrocalli”)
are deemed su?icient for sampling and establishing the mas

45

ter library. Under sterile conditions, petri dishes containing

results Were con?rmed in male Sprague-DaWley rat cerebrum

homogenates derived from animals sacri?ced by rapid

the surface-groWn macrocalli are opened and macrocalli are

individually sampled using ring forceps (4.8 mm inner ring

Preparation of membrane homogenates: Fresh tissue (bo
vine brain) Was procured immediately after euthanasia by
exsanguination. Alternatively, standards and replication of

50

decapitation. The preparation of these membranes Was iden
tical to bovine homogenates. Frontal cortex Was blocked, then

diameter, Fine Science Tools, Inc. Foster City, Calif.). This
ring siZe enables a section of tissue Weighing approximately

placed in ice-cold HEPES buffer (50 mM) for 10 min. Tissue

50 mg to be sampled. The removed tissue section is placed
into the numbered Well of a 48-Well microtiter plate contain

Was Weighed, and 4 ml of “incubation” buffer Was added.
Tissue Was homogeniZed in a 30 ml vol. glass hand-held

ing 0.4 ml fresh K4 media including required groWth regula

55

tissue homogeniZer With a te?on pestle. The crude homoge

custom made of DelrinTM plastic (12 cm in length><1-cm dia.)

nate Was Washed 3 times by centrifugation at 35,000><G for 20
min at 4° C. After each centrifugation, the homogenate Was

With the maceration end machined to a semi-circle (one-half
of the 1-cm circular end) is used to partially macerate the

re-suspended in fresh, cold buffer. FolloWing ?nal Washing, 1
ml aliquots Were snap-froZen in liquid nitrogen and stored in

tors. Once the 48-Well dishes are loaded, a maceration pestle,

tissue in the Well of the plate. Partial maceration is conducted
to break open a su?icient proportion of the cells Within the 50
mg piece of callus tissue to release the cellular contents for
analysis and to maintain an amount of this tissue (generally
about 1/3 of each callus section) in the Well to enable continued

60

groWth and recovery. Because the 3H-epibatidine displace

65

ment assay (beloW) can be used With K4 callus groWth media,
recovery and groWth of the microcalli Within the Wells is

a —20° C. freeZer until use. Prior to use in binding assays, total

protein concentration Was determined using a modi?ed

LoWry method (Sigma Kit) for membrane bound proteins.
Protein concentration effects and protein loss Were investi

gated by preparing aliquots of knoWn dilutions of membrane
protein suspension into Wells, ?ltering, and measuring the
protein concentration remaining on the plate ?lters via the

LoWry method.
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shoWed displacement activity in callus tissue extracts equiva

Competition binding: To reduce binding of radiolabel to

lent to alkaloid levels of several orders of magnitude over the

?lters, 0.1% BSA Was added to the assay buffer. Membranes
Were diluted With buffer to yield a ?nal protein concentration

Wild-type calli.

of 600 pg/Well (2 mg/ml). Membranes Were added to the

Example 8

Wells of a 96-Well microtiter plate and incubated at room

temperature With 10 nM [3H]-MLA, and unlabelled ligand or
unknown samples (100 pl each). Incubation Was halted after

Isolation and Replication of Activated Genes

2 hr by the addition of ice-cold buffer. The contents of the
microtiter plate Were harvested onto a 96 Well ?lterplate using
a plate harvester (Packard, Inc). Filters Were Washed 5>< With

Isolation: Molecular genetic techniques are conducted

using standard methodologies. The analytical sequence is
determined by isolating the plant genomic DNA activated by
the T-DNA insert through Southern hybridiZation analysis,
folloWed by polymerase chain reaction (PCR) to establish the

ice cold buffer and the ?lterplate dried overnight. Scintillation
cocktail Was then added to the ?lters and the entire plate

insert number and structure. Cloning of the T-DNA along
With ?anking genomic plant DNA Will depend on the struc
ture of the insert, ?rst utiliZing plasmid rescue for single site
T-DNA insertions. If there are multiple inserts, then genomic

counted using a TopCountTM 96-Well plate scintillation
counter, Packard Instruments, Meriden Conn.
Procedures for 3H-epibatidine binding in 96-Well ?lter
plates: All procedures Were performed at room temperature,
unless noted. Assays Were performed in standard (350 pl Well
volume) 96 Well microtiter plates. Nicotine or a sample com
petitor Was added to 8 Wells at a time using an 8-channel

libraries Will be prepared and screens conducted on these to

obtain genomic clones linked to the T-DNA that contain dif
20

multipipettor. Crude sample extracts Were solubiliZed using
1N HCl, if necessary. UnknoWn samples Were diluted With
incubation buffer (50 mM Tris-HCl, 120 mM NaCl, 5 mM

KCl, 1 nM MgCl2, 2 mM CaCl2, pH adjusted to 7.4) 1:10.

calli for the original phenotype. If necessary, subclones of the
recovered ?anking plant DNA can be prepared and tested for
25

This dilution alloWs an approximate Weight:volume ratio of
100 mg/ml of unknoWn sample per Well. 100 pl of a competi
tor Was added to each respective Well. Non speci?c binding
for epibatidine Was determined using 10 mM nicotine com
petition. Membrane homogenates Were thaWed on ice and
diluted With incubation buffer for ?nal protein concentration
of each Well equal to 4 mg/ml. Membrane homogenate prepa
ration Was added to 8 Wells at a time, using 8-channel pipettor.

30

A competitor Was incubated Within Wells for 1 hr. at room

35

activity by fusing various fragments doWnstream of the 35S
promoter of the Cauli?oWer mosaic virus, introducing these
back into protoplasts and scoring these cells for the pheno
type. Once the putative activated genomic DNA is identi?ed,
it is used as a probe to screen cDNA libraries of tobacco. In

addition, functional analysis to determine nicotinic alkaloid
pathWay upregulation can be performed by reverse transcrip

tion PCR using oligonucleotide primer speci?c to the pmt
gene of tobacco. This provides early molecular evidence if the
alkaloid pathWay Was induced in callus tissue, for example.

Example 9

temp. Following incubation of competitor, 3H-epibatidine
(New England Nuclear) Was added to each Well and incubated
for 2 hr. FolloWing incubation, the plate Was harvested onto a
96 Well GF/B ?lter plate using a Packard 96 Well harvester,
and rapidly Washed 3x With 350 pl 50 mM Tris-HCl buffer

ferent plant genomic DNA sequences. Resulting clones can

be sorted ?rst by Southern analysis and then functionally by
reintroduction into Wild-type protoplasts and scoring micro

We have prepared extracts from about 8000 clonal cultures
and have screened these for [3H]epibatidine-displacing activ
40

ity. Approximately 12 of these produced activity that met the
criteria of being “positive” in the ?rst screen. Of these, only

(pH:7.4). The plate Was then alloWed to dry overnight, then

three have met the criteria that daughter cultures should con

30 pl MicroScint20TM Was added to each Well before counting
With a Packard TopcountTM 96-Well plate scintillation
counter. Each Well Was counted for 2 min. Speci?c binding in
the presence of competitor Was converted to percentage of

tinue to overproduce activity in the screen through several
cycles of groWth and separation. The extent of the increase in
activity varies markedly betWeen these three clones. Thus, the

45

?rst clone isolated (#1402) producing a compound or com
pounds With a biological activity in the screen equivalent to a
concentration of nicotine an order of magnitude higher than

total speci?c binding of 3H-epibatidine alone. Signi?cant
differences Were calculated from CPM averages using Stu
dent’s 2 tailed t tests.

50

that produced by Wild-type cultures (see FIG. 8). A very
recent clone (#7309) is producing activity about 10,000>< that
of Wild-type Whereas the other clone (#5094) is intermediate

Example 7

betWeen these (FIG. 8). Because We isolated #1402 ?rst We

Results

have spent most time characterizing this clone, and the spe
ci?c ?ndings Will be described beloW.
55

tion tagged microcalli Were screened in a six month period.
This Was a 75% increase in ef?ciency over previous method

ologies.

sampled and separated Without destroying the individual cul
60

Identi?cation of Microcalli With Signi?cant Alkaloid-Dis
placing Activity: TWo stable cell lines Were identi?ed that
1402, Was examined at the Whole plant level and shoWed a

transformed plants. The second identi?ed isolate, 5094,

tures. Extracts from these cultures can therefore be sampled

and screened serially to evaluate Whether the genetically pro
duced chemical phenotype is stable. We have also shoWn that

shoWed signi?cant alkaloid-displacing activity. One of these,
7.5-fold increase in the level of displacement activity over the
Wild type in extracts prepared from leaf punches from non

The results shoW that ATM can be used to create a large

library of mutant clonal cultures (see FIG. 4) that can be
maintained by a small number of research Workers. We have
also shoWn that clones in this library can be repeatedly

Screening of Activation-Tagged Microcalli: 4400 activa

65

it is possible to adapt pharmacological HTS techniques to
evaluation of a clonal library produced by ATM, and that the
amplitude of changes in secondary metabolites from Wild
type or other control cultures that are produced by ATM can
be detected by this HTS. We are thus able to combine ATM

US 7,547,520 B2
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and HTSithe ?rst requirement for proof of the Natural Prod
ucts Genomics concept. Our results using this combination of
techniques shoW that a small number of clones (currently

more dif?cult than Would be expected. The problem is one of

best, but it is extraordinarily sensitive, being easily able to

around 1 in 2,700 mutants) can be regarded as stable alter
ations in genes that increase the synthesis of products With a

respond to picogram quantities of nicotine in a culture extract.
Chemical analytical methods such as GC/MS (as in FIG. 7)

sensitivity and quantitation. The screen is semi-quantitative at

biological activity similar to nicotine. These products may be

are about l000>< less sensitive, and to date We have not accu

nicotine itself, or some other chemical With activity in the
screen, at this stage We do not knoW. Similarly, the genes that
have been activated may have an impact on the nicotine
metabolic pathWay, or be completely unrelated to this. All We
knoW is that they increase the production of natural com

mulated enough clonal culture material to be able to analyZe
extracts quantitatively for knoWn and novel nicotine-like
alkaloids. We have therefore used a combination of pharma

pounds With potentially useful biological activity that is simi

type microcallus.

lar to that of nicotine. In fact, We may Well be underestimating
the numbers of clones that have this type of value. About 75%
of the clones that give a positive result in the ?rst screen

Nicotine is the most pharmacologically alkaloid in the
intact plant, and this alkaloid can be detected by GC/MS in
extracts from Wild-type cultures. Therefore, the most likely
reason for the increased activity in extracts from clonal cul
ture #1402 is that this is producing more nicotine than the
Wild-type cultures. This does not appear to be the case. Thus,

cological analysis and separation techniques to investigate
extracts of clone 1402 in comparison With extracts from Wild

eventually fail, sometimes after several generations of posi
tive daughter cultures. Some cultures even recover activity
after producing negative data for a While. In some cases, this
may indicate that We have activated a gene that regulates the

production of the natural product very indirectly, and that its

this clonal culture Was identi?ed on the basis of greater dis
20

effects can be over-ridden by other genes that may be acti
vated by environmental or developmental factors beyond our
control. HoWever, such genes might still be useful as a means

alpha3-containing nicAChRs on brain membranes. In con

trast, nicotine, and the partial agonist cytisine, have a higher
af?nity for nicAChRs on brain containing alpha4 subunits. If

of regulating synthesis of the natural product. We have been
deliberately conservative in our criteria to avoid the criticisms

25

previously associated With unstable somatic mutations in
plant cell culture. Considered together We believe that our
results demonstrate that ATM and HTS have the potential to
act as a discovery platform for those genes that regulate the

synthesis of natural products in plants. As our characteriza
tion of clone 1402 has shoWn (see beloW) this Natural Prod

the active principle in clone #1402 is nicotine it should dis
place [3H]nicotine or [3H]cytisine from brain membranes to
a greater extent than it displaces [3H]epibatidine. In fact the
reverse is the caseithe same extract from 1402 that is an

order of magnitude more effective at displacing epibatidine is
no more effective than that from Wild-type cultures in dis
30

ucts Genomics approach has utility as a drug discovery plat
form technology.
Clone 1402 has noW consistently over-produced activity in
the epibatidine displacement screen for about 18 months.
This has been in various incarnations of the original clonal

placement of epibatidine, a ligand With relative selectivity for

placing nicotine or (see FIG. 9). This suggests that Whatever
is responsible for the activity has a greater af?nity for alpha3

containing nicAChRs, and this is inconsistent With this being
nicotine or probably any of the other major alkaloids in

tobacco (see beloW).
35

FIG. 9 also shoWs another important pharmacological
characteristic of the culture extracts. The dilution/response

material that originated from a single protoplast subjected to

relation in the screens is very similar to that for pure nicotine.

ATM (see FIG. 8). Thus, daughter cultures of the original

This suggests that the displacement of the respective radioli
gands is by direct competition for the binding site, rather than

clone continued to overproduce activity in the screen. Some
of these cultures Were regenerated into intact plants Which set
seed. Extracts of the seed Were screened, and these continued
to shoW greater activity in the screen than Wild-type N
Zabacum seed. Plants Were groWn from this seed and leaf

punch extracts from young seedlings shoWed greater activity
in the screen than leaf punches from Wild-type seedlings. Leaf

40

gests an alkaloid that is a structural relative of nicotine rather

than a totally different type of compound. For example We

knoW that the cultures produce polyamines (see beloW) and
45

protoplasts from these plants Were groWn to the microcallus
level and these microcalli Were found to be still overproduc

50

from relatively mature plants. At this stage nicotine produc
tion is rising rapidly in the Wild-type plants and this might

dards (not shoWn here).
55

thesis and transport of nicotine. Our failure to observe a
difference in the screen betWeen clone 1402 and Wild-type

Since none of the major alkaloids in the plant have exactly
60

these characteristics, then We appear to have produced a
stable mutation that causes “overproduction” either of a com
pound that is not normally found in the plant, or one that is

normally produced in very small amounts. This ?nding, and

Since 1402 consistently overproduces activity in the epi
batidine displacement screen it Would seem to be a simple

Taken together, all this data is consistent With the produc
tion, by clone 1402, of an alkaloidal compound (or com
pounds) With structural similarity to nicotine, but Which bind

With high af?nity to nicAChRs containing alpha3 subunits.

plants at the mature plant stage illustrates the potential di?i
culties of evaluating differences in natural products in a popu
lation of mutant intact plants. Metabolic pro?ling of the
plants at this stage by GC/MS also did not reveal any differ
ences in alkaloid material (see FIG. 7).

and Wild-type cultures. We compared these fractions for
activity in the radioligand binding screens and also compared
the recovery in each phase With that of standards representing
the major alkaloids present in N Zabacum. In general, the
activity in extracts from #1402 shoWed a similar distribution
to that from Wild-type cultures and to that of alkaloid stan

Well eliminate the difference from the clonal plant. Addition

ally, assessing the production of nicotine-like alkaloids in leaf
punches from mature plants is subject to the Heisenberg
principle because leaf damage massively increases the syn

these compounds can affect nicAChR binding allosterically.
The suggestion that the compound in clone 1402 is structur
ally similar to the knoWn tobacco alkaloids is supported by
results from serial fractionation of the extracts from #1402

ing activity relative to Wild-type cultures.
The only situation in Which clone 1402 Was not found to be
an overproducer relative to Wild-type Was in leaf punches

by indirect or allosteric effects. This type of interaction sug

the procedure We used to come to this conclusion, has some
65

implications for drug discovery. Speci?cally, if the main pur

matter to establish What compound or compounds it is pro

pose of this technology is to discover clones that are produc

ducing that account for this activity. Unfortunately this is

ing active compounds other than the major active principle in
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b) groWing said protoplasts to the stage of callus culture
under selective conditions;
c) removing a tissue sample from the resulting individual

the plant, it is a simple matter to use differential activity in tWo
related screens to do this. Those clones that are simply over

producing the “Wild-type compound” Will produce a charac
teristic ratio of activity in the tWo screens. Those that are

callus cultures in such a manner so as to retain viability

producing some product With novel properties Will usually

of said callus cultures;
d) screening for the metabolite of interest in the tissue
sample in the event that the metabolite of interest is
present via a radiolabeled ligand binding assay, Wherein
the radiolabeled ligand binds nicotinic acetyleholine

produce a ratio of activity that differs from this.
Since the T-DNA that has been inserted into the N Zabacum

genome during the ATM procedure is “tagged” With bacterial
DNA, it is a relatively simple method to rescue this material

receptors.

together With sections of the plant genes surrounding it. HoW
ever, this does not guarantee that the piece of plant DNA that
is obtained is responsible for the altered chemical phenotype.

2. The method of claim 1, Wherein the metabolite of inter
est is detected.

3. The method of claim 2, Which further comprises the step
of propagating at least one daughter culture from the callus
culture in Which the metabolite of interest Was detected.
4. The method of claim 1, Wherein said plant is a tobacco

Thus the in?uence of the viral enhancer sequences inserted
into the genome extends for as much as 10-Kb pairs in each
direction from the insert, and it may be any gene Within this

range that is of value for natural product synthesis. Another

plant.

potential problem is that there may be more than one insert.
The important activation may be in one of these rather than

the other or, possibly, it could require both. Fortunately clone
#1402 has only one T-DNA insert and We have used plasmid
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rescue techniques to obtain genomic plant DNA from the
region of this insert. To date We have isolated approximately

sequence.

1.8-Kb pairs of this material (see FIG. 10), Which is probably
of insuf?cient length to encode a complete gene. HoWever,

the sequence analysis indicates very strongly suggests that
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the cloned genomic DNA does indeed encode intact genes in
that the deduced amino acid sequence from this region reveals
some homology With expressed genes When compared With

existing gene databanks. In particular, there is homology With
expressed sequence tags obtained from a soybean roots that
represents a gene of unknoWn function (FIG. 10). Since the
nicotine alkaloids are synthesized in roots, this at least shoWs

30

interest are rescreened at least one time for the presence of the
35

equivalents to the speci?c embodiments of the invention spe
ci?cally described herein. Such equivalents are intended to be
We claim:

least one transcription enhancer and at least one select

able marker gene in a plurality of plant protoplasts;

metabolite of interest by removing a tissue sample from each
of said callus cultures in such a manner so as to retain viability

encompassed in the scope of the folloWing claims.

1. A high throughput screening method for detecting a
metabolite of interest in a plant comprising;
a) causing integration of a T-DNA sequence encoding at

7. The method of claim 1, Wherein said radiolabeled ligand
is a nicotinic acetylcholine agonist.
8. The method of claim 1 Wherein said radiolabeled ligand
is a nicotinic acetylcholine antagonist.
9. The method of claim 4, Wherein said metabolite of
interest is detected With 3H-epibatidinc.
10. The method of claim 1 Wherein the tissue sample
removed in step (c) is used to establish a library of trans
formed callus cultures.
11. The method of claim 10 Wherein the transformed callus
cultures in the library that test positive for the metabolite of

the expected tissue speci?city.
Those skilled in the art Will recogniZe, or be able to ascer
tain using no more than routine experimentation, many

5. The method of claim 1, Wherein said transcription
enhancer is a plant viral transcription enhancer sequence.
6. A method of claim 5, Wherein said transcription
enhancer is an A grobaclerium Zumefaciens enhancer
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of the callus cultures.
12. The method of claim 10 further comprising the step of
isolating a gene involved in the production of the metabolite
of interest from a callus culture of the library that tests posi
tive for the metabolite of interest after at least one rescreening
for said metabolite of interest.

